During the past decade, E-Da Hospital conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 18 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 16 clinical trials were completed. i.e. 64% of trials that started reached the finish line.

Out of the total clinical trials conducted in "E-Da Hospital" #1 sponsor was "E-DA Hospital" with 14 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "National Taiwan University Hospital" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Daiichi Sankyo, Inc." with 4 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "E-Da Hospital" #1 collaborator was "E-DA Hospital" with 8 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "E-Da Hospital" are "Atrial Fibrillation" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Chronic Hepatitis B" (3 trials), "Crohn Disease" (3 trials) and "Hepatitis B, Chronic" (3 trials). Many other conditions were trialed in "E-Da Hospital" in a lesser frequency.

Most popular intervention types in "E-Da Hospital" are "Drug" (59 trials), "Other" (8 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (5 trials), "Cisplatin" (3 trials), "Lansoprazole" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "E-Da Hospital" are 74 trials for "All" genders.

Currently, there are NaN active trials in "E-Da Hospital". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in E-Da Hospital, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in E-Da Hospital, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 8 trials that are defined as “Not Applicable".